Company Filing History:
Years Active: 1995
Title: Judith Hampel: Innovator in Pharmaceutical Chemistry
Introduction
Judith Hampel is a notable inventor based in Cardiff, California, recognized for her contributions to pharmaceutical chemistry. She holds a patent that showcases her innovative approach to drug development, particularly in the area of angiotensin II receptor antagonists.
Latest Patents
Hampel's most recent patent is titled "Substituted [1H-imidazol-5-ylialkanoic acids having angiotensin II." This invention represents a significant advancement in the field, potentially offering new therapeutic options for conditions related to the angiotensin II pathway.
Career Highlights
Judith Hampel has made substantial contributions to her field while working at SmithKline Beecham Corporation. Her work has been instrumental in the development of new pharmaceutical compounds, and her innovative spirit continues to drive her research endeavors.
Collaborations
Throughout her career, Hampel has collaborated with esteemed colleagues, including Gerald R. Girard and David T. Hill. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Judith Hampel's work exemplifies the impact of innovation in pharmaceutical chemistry. Her patent and collaborations highlight her commitment to advancing medical science and improving patient outcomes.